Clinical Trial: Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S. Pneumoniae

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title:

Brief Summary: A COMPARASON OF CIDECIN™ (DAPTOMYCIN) TO ROCEPHIN® (CEFTRIAXONE) IN THE TREATMENT OF MODERATE TO SEVERE COMMUNITY-ACQUIRED ACUTE BACTERIAL PNEUMONIA DUE TO S. PNEUMONIAE

Detailed Summary:
Sponsor: Cubist Pharmaceuticals LLC

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Cubist Pharmaceuticals LLC

Dates:
Date Received: October 4, 2007
Date Started: July 2001
Date Completion:
Last Updated: July 16, 2015
Last Verified: October 2007